

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.85409444 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.85409444 |
| 3 | response to peptidoglycan (GO:0032494) | 4.55687693 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.50338173 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.50186728 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.40104775 |
| 7 | macrophage activation involved in immune response (GO:0002281) | 4.20211173 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00919638 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95876051 |
| 10 | negative regulation of cell killing (GO:0031342) | 3.95876051 |
| 11 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.94315712 |
| 12 | valine metabolic process (GO:0006573) | 3.91632622 |
| 13 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.81726981 |
| 14 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.79878015 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 3.79110205 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 3.76374130 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 3.56386723 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56108671 |
| 19 | type I interferon signaling pathway (GO:0060337) | 3.55316614 |
| 20 | cellular response to type I interferon (GO:0071357) | 3.55316614 |
| 21 | response to type I interferon (GO:0034340) | 3.53069447 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45289418 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.44444616 |
| 24 | germinal center formation (GO:0002467) | 3.43129259 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.42593694 |
| 26 | T-helper 1 type immune response (GO:0042088) | 3.41924156 |
| 27 | regulation of vitamin metabolic process (GO:0030656) | 3.39662038 |
| 28 | detection of other organism (GO:0098543) | 3.34959051 |
| 29 | low-density lipoprotein particle clearance (GO:0034383) | 3.33910921 |
| 30 | urea metabolic process (GO:0019627) | 3.31788423 |
| 31 | urea cycle (GO:0000050) | 3.31788423 |
| 32 | positive regulation of type 2 immune response (GO:0002830) | 3.29590110 |
| 33 | cysteine metabolic process (GO:0006534) | 3.24146944 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.22392404 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20311652 |
| 36 | interferon-gamma production (GO:0032609) | 3.17370348 |
| 37 | regulation of cholesterol storage (GO:0010885) | 3.17079074 |
| 38 | regulation of podosome assembly (GO:0071801) | 3.14365543 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.13259800 |
| 40 | defense response to protozoan (GO:0042832) | 3.12468425 |
| 41 | complement activation, alternative pathway (GO:0006957) | 3.10542663 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 3.08677848 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.05352698 |
| 44 | response to protozoan (GO:0001562) | 3.04445492 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.03816256 |
| 46 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01222604 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 2.99758612 |
| 48 | regulation of chronic inflammatory response (GO:0002676) | 2.98857988 |
| 49 | detection of bacterium (GO:0016045) | 2.98362615 |
| 50 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97720335 |
| 51 | regulation of hypersensitivity (GO:0002883) | 2.96149933 |
| 52 | response to muramyl dipeptide (GO:0032495) | 2.94952211 |
| 53 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.94562952 |
| 54 | protein carboxylation (GO:0018214) | 2.94562952 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94522153 |
| 56 | macrophage activation (GO:0042116) | 2.93850961 |
| 57 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93012070 |
| 58 | cellular response to ethanol (GO:0071361) | 2.92831576 |
| 59 | nitrogen cycle metabolic process (GO:0071941) | 2.92777634 |
| 60 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.89194175 |
| 61 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.89013104 |
| 62 | aromatic amino acid family catabolic process (GO:0009074) | 2.88330262 |
| 63 | L-phenylalanine catabolic process (GO:0006559) | 2.87321791 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.87321791 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84015684 |
| 66 | glycosphingolipid catabolic process (GO:0046479) | 2.83852359 |
| 67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83266284 |
| 68 | granulocyte activation (GO:0036230) | 2.82852096 |
| 69 | urate metabolic process (GO:0046415) | 2.82364013 |
| 70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.82334865 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 2.81832020 |
| 72 | tryptophan catabolic process (GO:0006569) | 2.81796020 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 2.81796020 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 2.81796020 |
| 75 | growth hormone receptor signaling pathway (GO:0060396) | 2.80625079 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 2.80592028 |
| 77 | amino-acid betaine metabolic process (GO:0006577) | 2.80454735 |
| 78 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80026272 |
| 79 | tryptophan metabolic process (GO:0006568) | 2.79064982 |
| 80 | positive regulation of interferon-beta production (GO:0032728) | 2.78944158 |
| 81 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.77983838 |
| 82 | regulation of interleukin-12 production (GO:0032655) | 2.77473064 |
| 83 | L-phenylalanine metabolic process (GO:0006558) | 2.76461834 |
| 84 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.76461834 |
| 85 | regulation of mononuclear cell migration (GO:0071675) | 2.75968492 |
| 86 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.75953918 |
| 87 | regulation of sequestering of triglyceride (GO:0010889) | 2.75426047 |
| 88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74794285 |
| 89 | myeloid cell activation involved in immune response (GO:0002275) | 2.74544849 |
| 90 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.74011947 |
| 91 | drug transmembrane transport (GO:0006855) | 2.73703749 |
| 92 | response to host immune response (GO:0052572) | 2.72112532 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.72112532 |
| 94 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.71538516 |
| 95 | negative regulation of T cell mediated immunity (GO:0002710) | 2.70873331 |
| 96 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.70243561 |
| 97 | regulation of T cell tolerance induction (GO:0002664) | 2.69272435 |
| 98 | microglial cell activation (GO:0001774) | 2.69179081 |
| 99 | positive T cell selection (GO:0043368) | 2.68894804 |
| 100 | detection of biotic stimulus (GO:0009595) | 2.68462021 |
| 101 | myeloid dendritic cell differentiation (GO:0043011) | 2.68330520 |
| 102 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.68307996 |
| 103 | phospholipid homeostasis (GO:0055091) | 2.67982585 |
| 104 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67353370 |
| 105 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.66708082 |
| 106 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66364943 |
| 107 | regulation of fever generation (GO:0031620) | 2.66232892 |
| 108 | regulation of interferon-beta production (GO:0032648) | 2.65804627 |
| 109 | positive regulation of heat generation (GO:0031652) | 2.65154413 |
| 110 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.64659506 |
| 111 | B cell mediated immunity (GO:0019724) | 2.63781980 |
| 112 | hepatocyte apoptotic process (GO:0097284) | 2.63523889 |
| 113 | negative T cell selection (GO:0043383) | 2.63189329 |
| 114 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.63076076 |
| 115 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.62676780 |
| 116 | regulation of type 2 immune response (GO:0002828) | 2.62622754 |
| 117 | oligosaccharide catabolic process (GO:0009313) | 2.61253109 |
| 118 | negative regulation of lipid storage (GO:0010888) | 2.61185029 |
| 119 | N-acetylneuraminate metabolic process (GO:0006054) | 2.61025940 |
| 120 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.60867481 |
| 121 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60659501 |
| 122 | cellular extravasation (GO:0045123) | 2.57961988 |
| 123 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.56680644 |
| 124 | neutrophil activation (GO:0042119) | 2.56466151 |
| 125 | thymic T cell selection (GO:0045061) | 2.56157031 |
| 126 | cellular response to lipopolysaccharide (GO:0071222) | 2.56020179 |
| 127 | glycolipid catabolic process (GO:0019377) | 2.55979931 |
| 128 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.55572813 |
| 129 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.55452852 |
| 130 | regulation of tolerance induction (GO:0002643) | 2.55389184 |
| 131 | cellular response to interferon-gamma (GO:0071346) | 2.55342765 |
| 132 | cellular response to molecule of bacterial origin (GO:0071219) | 2.55116630 |
| 133 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.54882894 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.54872951 |
| 135 | regulation of B cell differentiation (GO:0045577) | 2.51728712 |
| 136 | phospholipid efflux (GO:0033700) | 2.51569622 |
| 137 | negative thymic T cell selection (GO:0045060) | 2.51462781 |
| 138 | negative regulation of phagocytosis (GO:0050765) | 2.51376392 |
| 139 | lysine metabolic process (GO:0006553) | 2.50783616 |
| 140 | lysine catabolic process (GO:0006554) | 2.50783616 |
| 141 | kynurenine metabolic process (GO:0070189) | 2.49874719 |
| 142 | fatty acid transmembrane transport (GO:1902001) | 2.47900754 |
| 143 | regulation of cholesterol homeostasis (GO:2000188) | 2.47859504 |
| 144 | plasma lipoprotein particle clearance (GO:0034381) | 2.47435834 |
| 145 | regulation of triglyceride catabolic process (GO:0010896) | 2.45519042 |
| 146 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45129792 |
| 147 | lipid storage (GO:0019915) | 2.43405328 |
| 148 | modulation by symbiont of host immune response (GO:0052553) | 2.43137384 |
| 149 | positive regulation by symbiont of host defense response (GO:0052509) | 2.43137384 |
| 150 | modulation by symbiont of host defense response (GO:0052031) | 2.43137384 |
| 151 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.43137384 |
| 152 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.43137384 |
| 153 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.43137384 |
| 154 | positive regulation of histone deacetylation (GO:0031065) | 2.42620432 |
| 155 | glyoxylate metabolic process (GO:0046487) | 2.42036854 |
| 156 | homocysteine metabolic process (GO:0050667) | 2.41571996 |
| 157 | regulation of protein activation cascade (GO:2000257) | 2.40626356 |
| 158 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.38648323 |
| 159 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.38489717 |
| 160 | cellular response to growth hormone stimulus (GO:0071378) | 2.37466101 |
| 161 | 2-oxoglutarate metabolic process (GO:0006103) | 2.37221491 |
| 162 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.37160425 |
| 163 | carnitine metabolic process (GO:0009437) | 2.35986213 |
| 164 | response to growth hormone (GO:0060416) | 2.34936067 |
| 165 | T cell selection (GO:0045058) | 2.33593866 |
| 166 | drug transport (GO:0015893) | 2.32556754 |
| 167 | regulation of response to interferon-gamma (GO:0060330) | 2.32392679 |
| 168 | tricarboxylic acid metabolic process (GO:0072350) | 2.32368404 |
| 169 | regulation of complement activation (GO:0030449) | 2.31922882 |
| 170 | drug catabolic process (GO:0042737) | 2.31814832 |
| 171 | bile acid biosynthetic process (GO:0006699) | 2.31469572 |
| 172 | positive regulation of interferon-alpha production (GO:0032727) | 2.29974665 |
| 173 | fatty acid beta-oxidation (GO:0006635) | 2.29516329 |
| 174 | pinocytosis (GO:0006907) | 2.28609093 |
| 175 | positive regulation of lipid storage (GO:0010884) | 2.28085825 |
| 176 | fatty acid oxidation (GO:0019395) | 2.27922041 |
| 177 | positive regulation of lipid catabolic process (GO:0050996) | 2.27153041 |
| 178 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.23749242 |
| 179 | bile acid metabolic process (GO:0008206) | 2.23582805 |
| 180 | T cell migration (GO:0072678) | 2.22111972 |
| 181 | interferon-gamma secretion (GO:0072643) | 2.21963558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.19171055 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.04366000 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.46345198 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.25115230 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.21795561 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16163982 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.89990763 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.82917028 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.73760866 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67902288 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.55510984 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49706263 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49262036 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.46191220 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44114484 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39929348 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.39698788 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39370359 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.38574352 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38179593 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34885335 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.26411216 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17925184 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.10894810 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.06241672 |
| 26 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05292152 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02482421 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.00424258 |
| 29 | * MYB_26560356_Chip-Seq_TH2_Human | 2.00062667 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.88698860 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87734339 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87272101 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.86912992 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82617237 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.79679171 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.78440593 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.76487274 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70655260 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70364732 |
| 40 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69713457 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60672813 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58408972 |
| 43 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.57302684 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57262123 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56435016 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54407095 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52426862 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51119993 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50742073 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49725634 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47404903 |
| 52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.46499582 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43982413 |
| 54 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.41220001 |
| 55 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.40638769 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40101015 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38401057 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38370365 |
| 59 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38152393 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37200381 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36315954 |
| 62 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35666600 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34287030 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29006908 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28922450 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27888308 |
| 67 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27748894 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27627634 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26982114 |
| 70 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24580311 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21759705 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20881663 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19804078 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16805026 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13942319 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12816857 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12464309 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11268134 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09950955 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08065095 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07614275 |
| 82 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06862900 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05860000 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03920647 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 1.02001579 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01444301 |
| 87 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00101884 |
| 88 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00101884 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00034146 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.99111021 |
| 91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96289390 |
| 92 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96065419 |
| 93 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95775126 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95747184 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94978918 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94602243 |
| 97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93324668 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92917411 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92915579 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92648980 |
| 101 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92348381 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92184819 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91460914 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91021162 |
| 105 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90290234 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89927949 |
| 107 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.89821220 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89550564 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89490809 |
| 110 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89199611 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89052218 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88979634 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88886103 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88654650 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88481437 |
| 116 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88090003 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86894306 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86814381 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86191091 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84136415 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82972166 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82653726 |
| 123 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82131227 |
| 124 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81264594 |
| 125 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80905325 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80504411 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79829160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.49931252 |
| 2 | MP0005360_urolithiasis | 3.36030048 |
| 3 | MP0005365_abnormal_bile_salt | 2.89465409 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 2.44617214 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.42321709 |
| 6 | MP0004510_myositis | 2.32791000 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.29055395 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.21238676 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.18445074 |
| 10 | MP0003436_decreased_susceptibility_to | 2.13045061 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.03695448 |
| 12 | MP0003303_peritoneal_inflammation | 2.03391660 |
| 13 | MP0008004_abnormal_stomach_pH | 2.02136171 |
| 14 | MP0003252_abnormal_bile_duct | 2.00361738 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91830748 |
| 16 | MP0003763_abnormal_thymus_physiology | 1.90479325 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.88589477 |
| 18 | MP0005670_abnormal_white_adipose | 1.86904847 |
| 19 | MP0005671_abnormal_response_to | 1.82811554 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 1.80816518 |
| 21 | MP0002006_tumorigenesis | 1.74861258 |
| 22 | MP0009840_abnormal_foam_cell | 1.74568313 |
| 23 | MP0001800_abnormal_humoral_immune | 1.71940212 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.69407917 |
| 25 | MP0000609_abnormal_liver_physiology | 1.68718252 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.66458584 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.65273032 |
| 28 | MP0000685_abnormal_immune_system | 1.63575684 |
| 29 | MP0003724_increased_susceptibility_to | 1.63091496 |
| 30 | MP0005387_immune_system_phenotype | 1.61874919 |
| 31 | MP0001790_abnormal_immune_system | 1.61874919 |
| 32 | MP0004947_skin_inflammation | 1.57363885 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.56945862 |
| 34 | MP0005025_abnormal_response_to | 1.56684903 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.55357370 |
| 36 | MP0002419_abnormal_innate_immunity | 1.54910505 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.54302294 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.53321579 |
| 39 | MP0003075_altered_response_to | 1.52996061 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.52610840 |
| 41 | MP0002723_abnormal_immune_serum | 1.50974884 |
| 42 | MP0002254_reproductive_system_inflammat | 1.49568121 |
| 43 | MP0009785_altered_susceptibility_to | 1.48124314 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.46918542 |
| 45 | MP0009278_abnormal_bone_marrow | 1.46667787 |
| 46 | MP0006082_CNS_inflammation | 1.46310688 |
| 47 | MP0001819_abnormal_immune_cell | 1.45380106 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.45279460 |
| 49 | MP0004130_abnormal_muscle_cell | 1.44935179 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.40899938 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.38650058 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.36668357 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.35599042 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.34649803 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.34534184 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.32925072 |
| 57 | MP0003690_abnormal_glial_cell | 1.31729565 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.31181823 |
| 59 | MP0008260_abnormal_autophagy | 1.30289780 |
| 60 | MP0002398_abnormal_bone_marrow | 1.29147674 |
| 61 | MP0008469_abnormal_protein_level | 1.24766580 |
| 62 | MP0000343_altered_response_to | 1.24323069 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.23954695 |
| 64 | MP0003828_pulmonary_edema | 1.23469305 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.23105557 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.22665518 |
| 67 | MP0001853_heart_inflammation | 1.22323568 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.21537802 |
| 69 | MP0000604_amyloidosis | 1.21048567 |
| 70 | MP0003195_calcinosis | 1.20826604 |
| 71 | MP0005332_abnormal_amino_acid | 1.20257400 |
| 72 | MP0005451_abnormal_body_composition | 1.20207557 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.19778275 |
| 74 | MP0000716_abnormal_immune_system | 1.19354216 |
| 75 | MP0002405_respiratory_system_inflammati | 1.18476390 |
| 76 | MP0002118_abnormal_lipid_homeostasis | 1.17509142 |
| 77 | MP0000858_altered_metastatic_potential | 1.17033628 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.16278669 |
| 79 | MP0005166_decreased_susceptibility_to | 1.14455790 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 1.14405142 |
| 81 | MP0000689_abnormal_spleen_morphology | 1.12340269 |
| 82 | MP0002009_preneoplasia | 1.10714788 |
| 83 | MP0002722_abnormal_immune_system | 1.10205838 |
| 84 | MP0003186_abnormal_redox_activity | 1.07618321 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.07466948 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 1.07466948 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 1.06957508 |
| 88 | MP0002136_abnormal_kidney_physiology | 1.06489947 |
| 89 | MP0002796_impaired_skin_barrier | 1.05828769 |
| 90 | MP0003091_abnormal_cell_migration | 1.03825771 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 1.03812747 |
| 92 | MP0001873_stomach_inflammation | 1.00880250 |
| 93 | MP0009764_decreased_sensitivity_to | 1.00441580 |
| 94 | MP0002429_abnormal_blood_cell | 0.99275137 |
| 95 | MP0010307_abnormal_tumor_latency | 0.98334303 |
| 96 | MP0006054_spinal_hemorrhage | 0.97627116 |
| 97 | MP0009763_increased_sensitivity_to | 0.97049713 |
| 98 | MP0000598_abnormal_liver_morphology | 0.95083190 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.95073470 |
| 100 | MP0001216_abnormal_epidermal_layer | 0.94267955 |
| 101 | MP0000569_abnormal_digit_pigmentation | 0.93954850 |
| 102 | MP0001851_eye_inflammation | 0.93548895 |
| 103 | MP0003448_altered_tumor_morphology | 0.92724412 |
| 104 | MP0005375_adipose_tissue_phenotype | 0.92585456 |
| 105 | MP0005334_abnormal_fat_pad | 0.92475402 |
| 106 | MP0003868_abnormal_feces_composition | 0.92257060 |
| 107 | MP0002971_abnormal_brown_adipose | 0.92176436 |
| 108 | MP0003806_abnormal_nucleotide_metabolis | 0.91802390 |
| 109 | MP0000490_abnormal_crypts_of | 0.91267459 |
| 110 | MP0005164_abnormal_response_to | 0.90414140 |
| 111 | MP0005310_abnormal_salivary_gland | 0.89507754 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.89376902 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.88998604 |
| 114 | MP0001756_abnormal_urination | 0.88985034 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.88521172 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.88384993 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.87901692 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.86093921 |
| 119 | MP0009115_abnormal_fat_cell | 0.86027777 |
| 120 | MP0004883_abnormal_blood_vessel | 0.84635593 |
| 121 | MP0003866_abnormal_defecation | 0.84283954 |
| 122 | MP0001881_abnormal_mammary_gland | 0.82430548 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.82089894 |
| 124 | MP0003045_fibrosis | 0.76620494 |
| 125 | MP0008057_abnormal_DNA_replication | 0.76575329 |
| 126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76414565 |
| 127 | MP0001663_abnormal_digestive_system | 0.76316290 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.68733084 |
| 129 | MP0005165_increased_susceptibility_to | 0.67219607 |
| 130 | MP0004381_abnormal_hair_follicle | 0.66978892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.77318662 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.77318662 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.77318662 |
| 4 | Optic neuritis (HP:0100653) | 4.28172169 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.28172169 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.03304409 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.86224045 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.65208379 |
| 9 | Myocardial infarction (HP:0001658) | 3.55458259 |
| 10 | Complement deficiency (HP:0004431) | 3.37217537 |
| 11 | Stomatitis (HP:0010280) | 3.33566968 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.24783430 |
| 13 | Xanthomatosis (HP:0000991) | 3.21206483 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.20908431 |
| 15 | Loss of speech (HP:0002371) | 3.20567895 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 3.12894609 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.11068242 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.06555765 |
| 19 | Deep venous thrombosis (HP:0002625) | 3.04398247 |
| 20 | T lymphocytopenia (HP:0005403) | 3.03592955 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.99902617 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.93403538 |
| 23 | Pustule (HP:0200039) | 2.89458832 |
| 24 | Abnormality of T cell number (HP:0011839) | 2.87891911 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 2.87873300 |
| 26 | Recurrent fungal infections (HP:0002841) | 2.81675031 |
| 27 | Epidermoid cyst (HP:0200040) | 2.81506561 |
| 28 | Hypoglycemic coma (HP:0001325) | 2.81220095 |
| 29 | Recurrent viral infections (HP:0004429) | 2.79496790 |
| 30 | Joint hemorrhage (HP:0005261) | 2.79413187 |
| 31 | Keratoconjunctivitis (HP:0001096) | 2.76116671 |
| 32 | Abnormality of complement system (HP:0005339) | 2.74722130 |
| 33 | Gangrene (HP:0100758) | 2.73366449 |
| 34 | Nasal polyposis (HP:0100582) | 2.66991052 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 2.66045334 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.65781876 |
| 37 | Hyperglycinuria (HP:0003108) | 2.63285198 |
| 38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60042378 |
| 39 | Myositis (HP:0100614) | 2.57570749 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.57134119 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.56798180 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.53494499 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 2.52883597 |
| 44 | Disinhibition (HP:0000734) | 2.52349016 |
| 45 | IgM deficiency (HP:0002850) | 2.51393318 |
| 46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.51026524 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.50938824 |
| 48 | Purpura (HP:0000979) | 2.49885370 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.48636850 |
| 50 | Hemoptysis (HP:0002105) | 2.45505072 |
| 51 | Gingival bleeding (HP:0000225) | 2.42694703 |
| 52 | Hyperlipoproteinemia (HP:0010980) | 2.42085788 |
| 53 | Abnormality of T cells (HP:0002843) | 2.39637606 |
| 54 | Abnormality of the fingertips (HP:0001211) | 2.36681912 |
| 55 | Arterial thrombosis (HP:0004420) | 2.36296946 |
| 56 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.36072097 |
| 57 | Ketosis (HP:0001946) | 2.35776691 |
| 58 | Hematochezia (HP:0002573) | 2.34954436 |
| 59 | Increased IgE level (HP:0003212) | 2.32811592 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31260326 |
| 61 | Colitis (HP:0002583) | 2.29008605 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28790312 |
| 63 | Obstructive lung disease (HP:0006536) | 2.28790312 |
| 64 | Recurrent skin infections (HP:0001581) | 2.28500479 |
| 65 | Periodontitis (HP:0000704) | 2.28094844 |
| 66 | Malnutrition (HP:0004395) | 2.27284819 |
| 67 | Prolonged partial thromboplastin time (HP:0003645) | 2.26973109 |
| 68 | Hypobetalipoproteinemia (HP:0003563) | 2.24826119 |
| 69 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.24030601 |
| 70 | Hypoalphalipoproteinemia (HP:0003233) | 2.23925883 |
| 71 | Increased serum ferritin (HP:0003281) | 2.23591189 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.22742595 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.22515085 |
| 74 | Abnormality of macrophages (HP:0004311) | 2.22131310 |
| 75 | Abnormality of nucleobase metabolism (HP:0010932) | 2.22004750 |
| 76 | Hyperglycemia (HP:0003074) | 2.20061523 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.19226977 |
| 78 | Hypercholesterolemia (HP:0003124) | 2.18327965 |
| 79 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16793246 |
| 80 | Ketoacidosis (HP:0001993) | 2.16117682 |
| 81 | Amyloidosis (HP:0011034) | 2.15788731 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.14702716 |
| 83 | Abnormal platelet function (HP:0011869) | 2.14702716 |
| 84 | Pulmonary embolism (HP:0002204) | 2.14660656 |
| 85 | Urticaria (HP:0001025) | 2.14332436 |
| 86 | Hypolipoproteinemia (HP:0010981) | 2.13013794 |
| 87 | Orchitis (HP:0100796) | 2.12839636 |
| 88 | Upper motor neuron abnormality (HP:0002127) | 2.12392661 |
| 89 | Hyperammonemia (HP:0001987) | 2.12223830 |
| 90 | Abnormal platelet volume (HP:0011876) | 2.10711240 |
| 91 | Basal ganglia calcification (HP:0002135) | 2.10638608 |
| 92 | Increased IgM level (HP:0003496) | 2.09491575 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09352596 |
| 94 | Mucopolysacchariduria (HP:0008155) | 2.09352596 |
| 95 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.09169723 |
| 96 | Abnormality of glycine metabolism (HP:0010895) | 2.09169723 |
| 97 | Fat malabsorption (HP:0002630) | 2.06212374 |
| 98 | Gingivitis (HP:0000230) | 2.06155082 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 2.05400856 |
| 100 | Petechiae (HP:0000967) | 2.05164676 |
| 101 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05149766 |
| 102 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05149766 |
| 103 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.05137293 |
| 104 | Esophageal varix (HP:0002040) | 2.05061691 |
| 105 | Glomerulonephritis (HP:0000099) | 2.03937271 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 2.03812061 |
| 107 | Neurofibrillary tangles (HP:0002185) | 2.03764117 |
| 108 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02602921 |
| 109 | Joint swelling (HP:0001386) | 2.02513546 |
| 110 | Encephalitis (HP:0002383) | 2.02126806 |
| 111 | Prolonged bleeding time (HP:0003010) | 2.01931950 |
| 112 | Hepatocellular carcinoma (HP:0001402) | 2.01312942 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 2.01118930 |
| 114 | Hyperglycinemia (HP:0002154) | 2.00884613 |
| 115 | Anorexia (HP:0002039) | 2.00664638 |
| 116 | Chronic otitis media (HP:0000389) | 2.00426666 |
| 117 | Generalized aminoaciduria (HP:0002909) | 1.99842231 |
| 118 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99640294 |
| 119 | Dysostosis multiplex (HP:0000943) | 1.99564010 |
| 120 | IgA deficiency (HP:0002720) | 1.98972401 |
| 121 | Vasculitis (HP:0002633) | 1.98533044 |
| 122 | Mutism (HP:0002300) | 1.98109929 |
| 123 | Meningitis (HP:0001287) | 1.97325431 |
| 124 | Cortical dysplasia (HP:0002539) | 1.96780368 |
| 125 | Epistaxis (HP:0000421) | 1.96102370 |
| 126 | Polyneuropathy (HP:0001271) | 1.95439512 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.94896132 |
| 128 | Pancreatitis (HP:0001733) | 1.94698234 |
| 129 | Menorrhagia (HP:0000132) | 1.94508962 |
| 130 | Thrombocytosis (HP:0001894) | 1.94374095 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.93760678 |
| 132 | Thrombophlebitis (HP:0004418) | 1.91803183 |
| 133 | Cellulitis (HP:0100658) | 1.91121084 |
| 134 | Abnormality of the intrinsic pathway (HP:0010989) | 1.90920499 |
| 135 | Gout (HP:0001997) | 1.90045529 |
| 136 | Chronic diarrhea (HP:0002028) | 1.89741618 |
| 137 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89491482 |
| 138 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89491482 |
| 139 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89491482 |
| 140 | Abnormality of the prostate (HP:0008775) | 1.89278919 |
| 141 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83805739 |
| 142 | Apathy (HP:0000741) | 1.83736376 |
| 143 | Leukocytosis (HP:0001974) | 1.82441578 |
| 144 | Cerebral inclusion bodies (HP:0100314) | 1.81720488 |
| 145 | Chest pain (HP:0100749) | 1.81616691 |
| 146 | Bone pain (HP:0002653) | 1.81070609 |
| 147 | Slow saccadic eye movements (HP:0000514) | 1.79812786 |
| 148 | Hypergammaglobulinemia (HP:0010702) | 1.79808631 |
| 149 | Abnormality of the endocardium (HP:0004306) | 1.79218129 |
| 150 | Neuronal loss in central nervous system (HP:0002529) | 1.79139542 |
| 151 | Thin bony cortex (HP:0002753) | 1.78744940 |
| 152 | Abnormality of the pleura (HP:0002103) | 1.78500482 |
| 153 | Recurrent bronchitis (HP:0002837) | 1.78326472 |
| 154 | Vertigo (HP:0002321) | 1.76816304 |
| 155 | Premature loss of primary teeth (HP:0006323) | 1.76146877 |
| 156 | Hepatosplenomegaly (HP:0001433) | 1.74791153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 2.93609203 |
| 2 | PRPF4B | 2.91957042 |
| 3 | MAP4K1 | 2.91560863 |
| 4 | FGFR4 | 2.45196300 |
| 5 | TYK2 | 2.36468269 |
| 6 | MAP3K10 | 2.32044794 |
| 7 | GRK7 | 2.18153599 |
| 8 | STK10 | 2.15139177 |
| 9 | FGFR3 | 2.13853461 |
| 10 | JAK3 | 2.12304048 |
| 11 | TRIB3 | 2.11017697 |
| 12 | MATK | 2.07525614 |
| 13 | PKN2 | 2.04719658 |
| 14 | FRK | 2.04104258 |
| 15 | TXK | 2.03783254 |
| 16 | ERN1 | 2.00248274 |
| 17 | ITK | 1.91363028 |
| 18 | RIPK1 | 1.86249577 |
| 19 | MAP3K14 | 1.83843952 |
| 20 | JAK1 | 1.82073676 |
| 21 | FGR | 1.81982173 |
| 22 | ZAP70 | 1.81931505 |
| 23 | IRAK3 | 1.77501197 |
| 24 | IRAK4 | 1.77238749 |
| 25 | ACVR1B | 1.76850790 |
| 26 | BMPR2 | 1.73301209 |
| 27 | TAOK2 | 1.61651117 |
| 28 | EEF2K | 1.61591464 |
| 29 | CAMK1D | 1.60126048 |
| 30 | TGFBR2 | 1.58379926 |
| 31 | LATS1 | 1.54313790 |
| 32 | CDK6 | 1.50155610 |
| 33 | NEK9 | 1.49191743 |
| 34 | GRK6 | 1.43634451 |
| 35 | TBK1 | 1.41455535 |
| 36 | IRAK1 | 1.40592626 |
| 37 | JAK2 | 1.38850449 |
| 38 | BLK | 1.38783673 |
| 39 | TEC | 1.37872878 |
| 40 | MAP3K3 | 1.37450129 |
| 41 | IKBKE | 1.37358349 |
| 42 | MAP3K1 | 1.31654791 |
| 43 | FLT3 | 1.31622418 |
| 44 | STK3 | 1.30563041 |
| 45 | IRAK2 | 1.28157388 |
| 46 | SIK1 | 1.26283530 |
| 47 | MST1R | 1.23147606 |
| 48 | LRRK2 | 1.19553743 |
| 49 | INSRR | 1.19486686 |
| 50 | CSK | 1.19201718 |
| 51 | MAP2K3 | 1.17889196 |
| 52 | PIM1 | 1.16867565 |
| 53 | RPS6KA4 | 1.16370332 |
| 54 | SCYL2 | 1.16182983 |
| 55 | PTK6 | 1.15833842 |
| 56 | BTK | 1.14874655 |
| 57 | KIT | 1.13026952 |
| 58 | DDR2 | 1.11082771 |
| 59 | NLK | 1.11054908 |
| 60 | NME2 | 1.09317133 |
| 61 | STK24 | 1.08850673 |
| 62 | MAP3K6 | 1.06385188 |
| 63 | CDK12 | 1.04105401 |
| 64 | IKBKB | 1.03545989 |
| 65 | MAP3K2 | 0.99955310 |
| 66 | BCKDK | 0.99872717 |
| 67 | SYK | 0.97895611 |
| 68 | CDC42BPA | 0.97416005 |
| 69 | CSF1R | 0.95633628 |
| 70 | CDK4 | 0.95490980 |
| 71 | CHUK | 0.93188988 |
| 72 | PDPK1 | 0.91296295 |
| 73 | LCK | 0.90892237 |
| 74 | MOS | 0.87473936 |
| 75 | HIPK2 | 0.85500080 |
| 76 | PDK4 | 0.83617052 |
| 77 | PDK3 | 0.83617052 |
| 78 | CAMK1G | 0.81898785 |
| 79 | HCK | 0.81035988 |
| 80 | MARK3 | 0.79639370 |
| 81 | CAMKK2 | 0.76321095 |
| 82 | MAP3K11 | 0.75795407 |
| 83 | CDK9 | 0.75291643 |
| 84 | BMX | 0.72484388 |
| 85 | MST4 | 0.71298607 |
| 86 | KSR2 | 0.70776850 |
| 87 | NEK2 | 0.69716697 |
| 88 | LATS2 | 0.69560999 |
| 89 | YES1 | 0.68138728 |
| 90 | FGFR2 | 0.67169561 |
| 91 | MAPKAPK3 | 0.64285244 |
| 92 | MAP3K5 | 0.64170069 |
| 93 | MAPK11 | 0.63467584 |
| 94 | TAOK1 | 0.63224653 |
| 95 | PRKAA2 | 0.61456604 |
| 96 | BRD4 | 0.61303066 |
| 97 | FES | 0.59683654 |
| 98 | ICK | 0.56823305 |
| 99 | MAP3K9 | 0.55143342 |
| 100 | STK4 | 0.54698235 |
| 101 | EPHA3 | 0.54622112 |
| 102 | RPS6KC1 | 0.53258184 |
| 103 | RPS6KL1 | 0.53258184 |
| 104 | RIPK4 | 0.52028135 |
| 105 | TYRO3 | 0.51913412 |
| 106 | DYRK1B | 0.51850930 |
| 107 | GSK3A | 0.51719903 |
| 108 | SIK3 | 0.50872806 |
| 109 | SGK3 | 0.50282852 |
| 110 | PDK1 | 0.49626981 |
| 111 | LYN | 0.49343374 |
| 112 | SGK2 | 0.47922486 |
| 113 | ABL2 | 0.47861999 |
| 114 | RET | 0.47845873 |
| 115 | MARK2 | 0.47412225 |
| 116 | ABL1 | 0.47399107 |
| 117 | MAP3K7 | 0.47275374 |
| 118 | PRKAA1 | 0.45627722 |
| 119 | PDGFRB | 0.44390440 |
| 120 | DYRK3 | 0.43726042 |
| 121 | MAPK7 | 0.42766438 |
| 122 | MAP3K8 | 0.42716606 |
| 123 | PIK3CG | 0.42557715 |
| 124 | NUAK1 | 0.41238738 |
| 125 | RPS6KB2 | 0.40668209 |
| 126 | MAP3K13 | 0.40242307 |
| 127 | PRKCQ | 0.39738700 |
| 128 | EGFR | 0.39512378 |
| 129 | PDGFRA | 0.39192131 |
| 130 | MELK | 0.38699026 |
| 131 | RPS6KA6 | 0.38088876 |
| 132 | TRPM7 | 0.35948727 |
| 133 | MTOR | 0.34417622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63049313 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.51147912 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.50594934 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.05867971 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00933433 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97820118 |
| 7 | Asthma_Homo sapiens_hsa05310 | 1.95379632 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.94260842 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.85995209 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.83793325 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78265349 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.74330839 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74135397 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72770770 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.72650212 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69889967 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.69202713 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57317930 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56987819 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.52413436 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46260223 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44690760 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43512641 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41520395 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41418722 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40083040 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.39998483 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38310896 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35366251 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.31521878 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.25016995 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.23599822 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.23425305 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16972771 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16660164 |
| 36 | Insulin resistance_Homo sapiens_hsa04931 | 1.14452872 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14387183 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14303216 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.12697679 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12281425 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11352538 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09878754 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09742705 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.07908794 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07084559 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.06055332 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05494206 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05110643 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03689788 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03349777 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03143980 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.00994510 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99559568 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99190117 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99133630 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.97803349 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.97548631 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96155334 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96096929 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95092591 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95001716 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93266621 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91738453 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91362894 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.89349441 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.87901495 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87899303 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87265772 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86809154 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86460183 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86420880 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86308429 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.85965128 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85955627 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85139215 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85040407 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84767972 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.84416126 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84294354 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.82719610 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81977701 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.81506606 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80835499 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.80620170 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78609140 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.78369897 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78164531 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.77545441 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77155677 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75084466 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74494601 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74358678 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73458972 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73101577 |
| 95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72699438 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72404484 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72118604 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72028759 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71386684 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70862770 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.70066557 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69753760 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69389068 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69284203 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68546694 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.68152418 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66151705 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64626410 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.62590886 |
| 110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62123436 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61762090 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61211010 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60400809 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59815977 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58664666 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57073609 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.55957275 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55639261 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54531356 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54096003 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52855566 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52587492 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.49749849 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49609013 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48011621 |
| 126 | Allograft rejection_Homo sapiens_hsa05330 | 0.47449411 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46201045 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46122772 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44525469 |
| 130 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44332824 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43667944 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43313999 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42812824 |
| 134 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42615902 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41527149 |
| 136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40726255 |
| 137 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40697807 |
| 138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40666722 |
| 139 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40573732 |
| 140 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38758143 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38558633 |
| 142 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37574907 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35216309 |
| 144 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34882824 |
| 145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33909915 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.30481656 |
| 147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30180975 |

